NCT00027729View on ClinicalTrials.gov

Monoclonal Antibody Therapy in Treating Patients With Advanced Colorectal Cancer

PHASE1/PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

June 30, 2001

Primary Completion Date

November 30, 2004

Study Completion Date

November 30, 2004

Conditions
Colorectal Cancer
Interventions
BIOLOGICAL

etaracizumab

Trial Locations (1)

10021

Memorial Sloan-Kettering Cancer Center, New York

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT00027729 - Monoclonal Antibody Therapy in Treating Patients With Advanced Colorectal Cancer | Biotech Hunter | Biotech Hunter